Evidence map›Paper›PMID 35803909›Full record

ArticleNature communications2022

The effect of COVID certificates on vaccine uptake, health outcomes, and the economy.

Miquel Oliu-Barton, Bary S R Pradelski, Nicolas Woloszko, Lionel Guetta-Jeanrenaud, Philippe Aghion, Patrick Artus, Arnaud Fontanet, Philippe Martin, Guntram B Wolff

Abstract read
In one paragraph

Article in Nature communications, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 45 papers.

0numbers the graph read from it
0cells of the map it votes in
45citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

45 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Nonstructural barriers to adult vaccination.Human vaccines & immunotherapeutics · 2024
    Article
  12. Article
  13. Review
  14. Article
  15. Do COVID-19 Vaccination Policies Backfire? The Effects of Mandates, Vaccination Passports, and Financial Incentives on COVID-19 Vaccination.Perspectives on psychological science : a journal of the Association for Psychological Science · 2024
    Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Miquel Oliu-BartonUniversité Paris-Dauphine, Paris, France. miquel.oliu.barton@normalesup.org.
Bary S R PradelskiFrench National Centre for Scientific Research (CNRS), Paris, France. bary.pradelski@cnrs.fr.ORCID 0000-0003-2418-0037
Nicolas WoloszkoOrganisation for Economic Co-operation and Development (OECD), Paris, France. nicolas.woloszko@oecd.org.ORCID 0000-0001-5106-8388
Lionel Guetta-Jeanrenaud, Bruegel, Belgium.
Philippe AghionCollège de France and INSEAD, Paris, France.
Patrick ArtusNatixis and Paris School of Economics, Paris, France.
Arnaud FontanetInstitut Pasteur and Conservatoire National des Arts et Métiers, Paris, France.
Philippe MartinSciences Po and CEPR, Paris, France.
Guntram B Wolff, Bruegel, Belgium.ORCID 0000-0003-2716-522X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In the COVID-19 pandemic many countries required COVID certificates, proving vaccination, recovery, or a recent negative test, to access public and private venues. We estimate their effect on vaccine uptake for France, Germany, and Italy using counterfactuals constructed via innovation diffusion theory. The announcement of COVID certificates during summer 2021 were associated - although causality cannot be directly inferred - with increased vaccine uptake in France of 13.0 (95% CI 9.7-14.9) percentage points (p.p.) of the total population until the end of the year, in Germany 6.2 (2.6-6.9) p.p., and in Italy 9.7 (5.4-12.3) p.p. Based on these estimates, an additional 3979 (3453-4298) deaths in France, 1133 (-312-1358) in Germany, and 1331 (502-1794) in Italy were averted; and gross domestic product (GDP) losses of €6.0 (5.9-6.1) billion in France, €1.4 (1.3-1.5) billion in Germany, and €2.1 (2.0-2.2) billion in Italy were prevented. Notably, in France, the application of COVID certificates averted high intensive care unit occupancy levels where prior lockdowns were instated.

Indexed as

COVID-19VaccinesCommunicable Disease ControlFranceGermanyHumansItalyOutcome Assessment, Health CarePandemicsVaccines

Identifiers

PMID35803909
PMCPMC9263819

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.